Home     |     Contact Us

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Latest News Innovations World of Getwell
  • Getwell participated in the 4th PHARMED & HEALTHCARE VIETNAM 2009, exihibition hosted by Central Health Communication and Education Center, VIETFAIR J.S.C & VIMEDIMEX VN from September 23rd - 26th, 2009 held at Ho Chi Minh City.

  • Getwell launches, I-Dox (Pegylated Liposomal Doxorubicin) in the Indian market.

  • Jan 2009 - Getwell got WHO-GMP approval

  • April 2009 - Preclinical studies on generic Pegylated Liposomal Doxorubicin was initiated

  • June 2009 - Preclinical studies are reported successful.
We at Getwell are passionate for innovation, unrelenting in our efforts for cancer critical care and realistic of our ability to serve patients across the globe suffering from the clutches of cancer. We are focused to pursue the right modalities through continuous development and manufacturing.

At Getwell, we have a wide select of oncology options, ranging from traditional cell killing chemotherapeutic agents to specific transduction inhibitors, target therapy and newer generation immuno-modulators.

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

 

Buzz at Getwell    |   

Copyright© 2011-12 World of Getwell. All Right Reserved.